$UNCY
Unicycive Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.21
▼-0.42%-$0.018
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateUnicycive Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is UNCY down today? It is at $4.21 (-0.42%), and our scanner flagged it 57 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment UNCY spikes, and full due diligence on UNCY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $UNCY 57 times in the last 30 days. Create a free account to track $UNCY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on UNCY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for UNCY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing3Initial insider ownership (Form 3)Oct 1, 2026 · 6 days agoAcross every filing on file, supply equal to 85% of the tradeable float is in play - 85% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Active shelf on file — the company can issue new shares on demand (valid ~3 years)
About $50.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Aggarwal Gaurav Director | Acquired (grant/award) | +653K 2.3% of company | added 57% | 1.79M | n/a | Aug 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on UNCY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for UNCY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
UNCY last traded at $4.21, down 0.42% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Unicycive Therapeutics, Inc. Common Stock (UNCY) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The UNCY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged UNCY 57 times in the last 30 days.
UNCY (Unicycive Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $116M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge UNCY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$UNCY discussion
Sign in to ask a question or join the discussion.